Alaa Bassuny Ismael

Prof. Dr. Alaa Bassuny Ismael


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2003 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
AIAlaa Bassuny Ismael
Alaa Bassuny Ismael
DSDalila Sekkai
Dalila Sekkai
CCChristine Collin
Christine Collin
DBDaniel Bout
Daniel Bout
MMMarie-NoëlLe MévÉlEc
Marie-NoëlLe MévÉlEc
Infection with the intracellular protozoan parasiteToxoplasma gondiicauses serious public health problems and is of great economic importance worldwide. The micronemal protein MIC3, which is a potent adhesin ofT. gondii, could be a significant candidate vaccine against toxoplasmosis. In this study, all CBA/J mice intramuscularly vaccinated with a plasmid encoding the immature form of the MIC3 protein (pMIC3i) produced specific anti-MIC3 immunoglobulin G (IgG) antibodies, and their sera displayed high antibody titers. This response was increased by the coadministration of a plasmid encoding the granulocyte-macrophage colony-stimulating factor (pGM-CSF). Similarly, a specific and significant cellular immune response was obtained in mice immunized with pMIC3i, and this response was markedly enhanced by pGM-CSF coadministration. The cellular immune response was associated with the production of gamma interferon IFN-γ and interleukin-2 (IL-2), indicating that this was a Th1-type response. This was confirmed by the production of large amounts of IgG2a. Mice immunized with pMIC3i displayed significant protection against an oral challenge withT. gondii76K cysts, exhibiting fewer brain cysts than did the control mice. Coadministration of pGM-CSF enhanced this protection. In conclusion, this study describes the design of a potent DNA vaccine encoding the novelT. gondiitarget antigen, MIC3 protein, that elicits a strong specific immune response as well as providing effective protection againstT. gondiiinfection. In the attempt to achieve complete protection against toxoplasmosis, MIC3 is a good candidate vaccine which could be combined with other relevant and previously described candidates, such as SAG1 and GRA4.

13 April 2010 in Veterinary Research
Verified
Journal Article
Open access
PDF file
MMMarie-Noëlle Mévélec
Marie-Noëlle Mévélec
CDCéline Ducournau
Céline Ducournau
AIAlaa Bassuny Ismael
Alaa Bassuny Ismael
MOMichel Olivier
Michel Olivier
ÉSÉdouard Sèche
Édouard Sèche
IDIsabelle Dimier-Poisson
Isabelle Dimier-Poisson
This study assessed the effectiveness of a mutant strain of Toxoplasma gondii (RH strain) lacking the mic1 and mic3 genes (Mic1-3KO) against Toxoplasma abortion in sheep. Ewes were inoculated subcutaneously with 10(5) Mic1-3KO tachyzoïtes in three independent experiments. Following vaccination, Mic1-3KO induced a mild febrile response and serum IgG antibodies, which persisted throughout the experiments. Tissue cysts formed in the sheep, but were not, under our experimental conditions, infectious when given orally. Ewes were mated two months after vaccination and were orally challenged with the PRU strain of T. gondii at mid-gestation (400 oocysts in Experiments 1 and 2; 100 oocysts in Experiment 3). Challenge of vaccinated pregnant ewes resulted in a slight febrile response, whereas unvaccinated ewes developed a more severe, characteristic febrile response of longer duration. After challenge, all unvaccinated ewes aborted whereas 62%, 91% and 64% (Experiments 1, 2 and 3 respectively) of the lambs from vaccinated ewes were viable, with no clinical signs of infection. Mic1-3KO was as effective as S48, the strain used as a live vaccine for sheep (Toxovax). A dose of 10(5) Mic1-3KO tachyzoites was sufficient to induce protection (versus a dose of 2x10(6)). Both subcutaneous and intraperitoneal injections were effective. Moreover, preliminary results showed the potential of Mic1-3KO to reduce the development of tissue cysts in lambs born to vaccinated ewes. This study demonstrates that Mic1-3KO is a potent vaccine candidate.

15 October 2006 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
AIAlaa Bassuny Ismael
Alaa Bassuny Ismael
IDIsabelle Dimier‐Poisson
Isabelle Dimier‐Poisson
MLMaryse Lebrun
Maryse Lebrun
JDJean‐François Dubremetz
Jean‐François Dubremetz
DBDaniel Bout
Daniel Bout
MMMarie‐Noëlle Mévélec
Marie‐Noëlle Mévélec
BackgroundWe evaluated a new vaccine, Mic1-3KO, against both chronic and congenital toxoplasmosis in mice. Mic1-3KO is a mutant strain of Toxoplasma

1 June 2014 in Bulletin of the Veterinary Institute in Pulawy
Verified
Journal Article
Open access
PDF file
Ayman Abdel Aziz SwelumAyman Abdel Aziz Swelum
Ayman Abdel Aziz Swelum
AIAlaa Bassuny Ismael
Alaa Bassuny Ismael
AKAhmed F. Khalaf
Ahmed F. Khalaf
MAMohamed Abouheif
Mohamed Abouheif

1 May 2009 in Vaccine
Verified
Journal Article
Closed access
AIAlaa Bassuny Ismael
Alaa Bassuny Ismael
DHDorsaf Hedhli
Dorsaf Hedhli
OCOdile Cérède
Odile Cérède
MLMaryse Lebrun
Maryse Lebrun
IDIsabelle Dimier-Poisson
Isabelle Dimier-Poisson
MMMarie-Noëlle Mévélec
Marie-Noëlle Mévélec

1 January 2016 in Journal of Camel Practice and Research
Verified
Journal Article
Closed access
PDF file
AIAlaa Bassuny Ismael
Alaa Bassuny Ismael
Ayman Abdel Aziz SwelumAyman Abdel Aziz Swelum
Ayman Abdel Aziz Swelum
AKA.F. Khalaf
A.F. Khalaf
AAA.N. Alowaimer
A.N. Alowaimer
Ninety-six of 237 dromedary camels manifested fever, anorexia, diarrhoea, emaciation, pale mucous membranes, lacrimation, abortion and/or infertility. Parasitological examinations of blood and faecal samples were performed in all camels (n=237) using Giemsa-stained blood smears and standard flotation sedimentation techniques, respectively. Seventy-two of the clinically affected camels were diagnosed anaplasmosis with a 40.50% overall morbidity. The haematological analysis revealed significant reduction (P<0.01) in total RBC count, HGB concentration, HCT and MCV in the affected camels. Additionally, significant increases (P<0.01) in total WBC count, lymphocytes %, MCHC and platelets were observed. The biochemical analysis exposed significant reduction (P<0.001) in the iron level. Significant increases (P<0.01) in GGT, AST, ALT, total bilirubin, BUN and LDH blood levels were detected. The applied control measures succeeded in controlling anaplasmosis in affected herds. In conclusion, the successful in the control of camel anaplasmosis and its first diagnosis was achieved in Saudi Arabia dromedary camel.